The expression of RNF43 and LRP1B correlated significantly with tumor type according to Lauren, i.e., both were significantly reduced in diffuse type GC, adding them to an increasing list of WNT pathway components, which are differentially mutated and expressed in diffuse and intestinal type GC. Here, RNF43 is linked to gastric cancer.